Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Hepatology"
DOI: 10.1016/s0168-8278(17)30435-x
Abstract: 193 • HCV NS3/4A protease inhibitor • 50 mg per tablet • HCV NS5A next-generation inhibitor • 30 mg per tablet • HCV NS5B polymerase nucleotide inhibitor • 225 mg per tablet Ruzasvir (MK-8408) Grazoprevir… read more here.
Keywords: 100 100; weeks rbv; rbv weeks; hcv ... See more keywords